Home / NEWS / Top News / Eli Lilly’s strong quarter, promising obesity drug data show why we like the stock

Eli Lilly’s strong quarter, promising obesity drug data show why we like the stock

It was another affluent quarter and fantastic pipeline update from Eli Lilly, a best-in-class name in the pharmaceutical industry.

Check Also

Stock futures rise after Dow falls for 8th-straight week in relentless sell-off

Standard futures rose in overnight trading Sunday after the Dow fell for its 8th straight …

Leave a Reply

Your email address will not be published. Required fields are marked *